Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Multinational, Multicenter, Double-blind, Placebo-controlled, Two-arm Parallel Group Trial of Rimonabant 20 mg OD for Reducing the Risk of Major Cardiovascular Events in Abdominally Obese Patients With Clustering Risk Factors

NCT00263042 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT00263042
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00263042 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Multinational, Multicenter, Double-blind, Placebo-controlled, Two-arm Parallel Group Trial of Rimonabant 20 mg OD for Reducing the Risk of Major Cardiovascular Events in Abdominally Obese Patients With Clustering Risk Factors
Lead sponsor
Sanofi
Phase
Phase 3
Overall status
Terminated
Start date
December 31, 2005
Completion date
April 30, 2009
Enrollment
18,695 (actual)
Sites
43

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular disease